replacement), indicates an enrichment of stem cell markers upon castration; CD44, NKX3.1 and ALDH1 isoforms. Microarray analysis has confirmed upregulation of CD44 and ALDH1A1 at castrated state, versus downregulation upon androgen replacement at early time points (24 hours). We isolated CD44þ/-ALDHhigh/low subpopulations by flow cytometry for transcriptome analysis. Castration in the BM-18 model induces an increase in the subpopulations of CD44þ/ALDHlow (from 0.44% to 2.3%) and CD44þ/ALDHhigh (from 0.06% to 0.38%). However, the same subpopulations are not increased in the LAPC-9 model upon castration, while only the CD44-/ALDHhigh subset is enriched (from 3.5% to 7.1%). Organoids derived from bulk BM-18 and LAPC-9 tumors are reestablishing tumor formation upon intraosseous inoculation.
INTRODUCTION AND OBJECTIVES: Tumor heterogeneity can be traced back to a small subset of cancer stem cells (CSCs), which can be derived from a single stem cell and show chemo-resistance. Recent studies showed that CSCs are sensitive to the drug which targets mitochondrial phosphorylation. However, little is known about how cancer cells undergo sphere formation and how the drugs inhibit CSC proliferation.
METHODS: We cultured prostate cancer cell line (PC-3, LNCap, Du-145) under the non-adherent condition using sphereforming assay. Notably, Cells were plated in serum-free medium DMEM/F12 containing B27 without Vitamine A, 20 ng/ml EGF and 0.4% PenStrep in non-adherent conditions, in NunclonTM sphere dishes. All experiment was compared with the attached culture condition. All xenograft analysis was performed under the guidelines of the Kyushu University Animal Research Facility and were approved by the Kyushu University Institutional Care and Use Committee under Protocol #A29-052-0.
RESULTS: We show that under sphere-forming assay conditions, prostate cancer cells acquired CSC-like properties: promoted mitochondrial respiratory chain activity, expression of characteristic CSC markers and resistance to anticancer agents. Furthermore, those CSC-like properties could reversibly change depending on the culture conditions, suggesting some kinds of the properties have plasticity in tumor microenvironments. The sphere-forming cells (i.e. cancer stemlike cells) showed increased contact between mitochondria and mitochondrial associated-endoplasmic reticulum (ER) membranes (MAM). Mitochondrial targeting doxycycline-induced activating transcription factor 4 (ATF4) mediated expression of ER stress response and led to p53-upregulated modulator of apoptosis (PUMA)-dependent apoptosis only in the cancer stem-like cells. We also found that doxycycline effectively suppressed the sphere formation in vitro and blocked CD44v9-expressing tumor growth in vivo.
CONCLUSIONS: these data provide new molecular findings that monolayer cancer cells acquire CSC-like properties in a reversible manner. These findings provide important insights into CSC biology and a potential new treatment of targeting mitochondria dependency.
Source of Funding: none

MP81-18 INTRACAVERNOUS INJECTION OF BONE MARROW MESENCHYMAL STEM CELLS MODIFIED WITH PDE5-RNAI IMPROVES ERECTILE DYSFUNCTION IN AGED RATS
Hengjun Xiao*, Weixin Yan, Yubin Cui, Jun Chen, Liaoyuan Li, Guangzhou, China, People's Republic of INTRODUCTION AND OBJECTIVES: To determine the effect of intracavernous injection of bone marrow mesenchymal stem cells (BMSCs) genetically modified with PDE5-RNAi on erectile dysfunction (ED) in aged rats.
METHODS: BMSCs collected from Sprague-Dawley (SD) male rats of six weeks were transfected with lentivirus modified with PDE5-RNAi. Sixty male SD rats were equally divided into six groups: (i) A control group of normal rats (n¼10), (ii) A control group of Aged rats (n¼10), (iii) A negative control group of aged rats treated with PBS (n¼10), (iv) aged rats treated with BMSCs alone (n¼10), (v) aged rats treated with BMSCs modified with lentivirus-PDE5-RNAi (n¼10), (vi) aged rats treated with lentivirus-PDE5-RNAi (n¼10). ED was screened with apomorphine (100 mg/kg). Cell injections occurred directly into the corpora cavernosa (1Â106 cells). The ratio of intracavernosal pressure (ICP) to mean arterial pressure (MAP), expression of endothelial markers (such as CD31 and eNOS), smooth muscle markers (such as a-SMA and desmin), VEGF, b-FGF, Angiopoietin-1 and the relative area of smooth muscle to collagen using masson trichrome staining were assessed for each group.
RESULTS: Implanted BMSCs modified with PDE5-RNAi displayed a significantly raised ICP and ICP/MAP ratio (p < 0.05) compared with BMSCs and lentivirus-PDE5-RNAi alone in 14 days after intracavernous injection. Immunofluorescence staining displayed expression of CD31, eNOS and a-SMA was increased in BMSCs alone or BMSCs modified with PDE5-RNAi groups in aged rats after 2 weeks. Western blot analysis and quantitative analysis for western blot confirmed the significantly increased expression of CD31, eNOS and a-SMA (p < 0.05).VEGF, b-FGF, and Angiopoietin-1 were also significantly elevated 2 weeks following BMSCs modified with PDE5-RNAi injection (p < 0.05). After receiving intracaverous injection of BMSCs modified with PDE5-RNAi, smooth muscle cells/collagen ratio significantly increased confirmed by Masson's trichrome-staining. Vol. 199, No. 4S, Supplement, Monday, May 21, 2018 THE JOURNAL OF UROLOGY â e1103
